{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "MAP2K2",
                "DNA Alteration": "c.383C>T",
                "GeneMutation": "p.P128L Spliceregionvariant-LOF",
                "VariantAlleleFraction": "14.7%"
            },
            {
                "Gene": "ALK",
                "DNA Alteration": "c.3260C>T",
                "GeneMutation": "p.F1245X Frameshift-LOF",
                "VariantAlleleFraction": "7.53%"
            },
            {
                "Gene": "ALK",
                "DNA Alteration": "c.3512_3513delinsAT",
                "GeneMutation": "p.L1196M Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "1.26%"
            },
            {
                "Gene": "SRSF2",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.P95X Frameshift-LOF",
                "VariantAlleleFraction": "6.87%"
            },
            {
                "Gene": "DPYD",
                "DNA Alteration": "c.557A>G",
                "GeneMutation": "p.I560S Nonsense-GOF",
                "VariantAlleleFraction": "8.98%"
            },
            {
                "Gene": "CHEK2",
                "DNA Alteration": "c.470T>C",
                "GeneMutation": "p.S428F Spliceregionvariant-GOF",
                "VariantAlleleFraction": "5.3%"
            },
            {
                "Gene": "DDR2",
                "DNA Alteration": "c.1912A>T",
                "GeneMutation": "p.I638F Spliceregionvariant-GOF",
                "VariantAlleleFraction": "8.49%"
            },
            {
                "Gene": "RB1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.F650S Spliceregionvariant-GOF",
                "VariantAlleleFraction": "9.72%"
            },
            {
                "Gene": "HSD3B1",
                "DNA Alteration": "c.1100=",
                "GeneMutation": "p.T367N Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "2.78%"
            },
            {
                "Gene": "STAT5B",
                "DNA Alteration": "c.1924A>C",
                "GeneMutation": "p.N713_A714insKGKGGG Nonsense-GOF",
                "VariantAlleleFraction": "2.47%"
            },
            {
                "Gene": "NCSTN",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.A572G Nonsense-LOF",
                "VariantAlleleFraction": "7.84%"
            },
            {
                "Gene": "MAP2K2",
                "DNA Alteration": "c.383C>T",
                "GeneMutation": "p.P128L Spliceregionvariant-LOF",
                "VariantAlleleFraction": "8.73%"
            }
        ],
        "Germline": []
    }
}